Page last updated: 2024-11-08

methyldimethylaminoazobenzene and Cirrhosis

methyldimethylaminoazobenzene has been researched along with Cirrhosis in 1 studies

Methyldimethylaminoazobenzene: A very potent liver carcinogen.
3-methyl-4'-dimethylaminoazobenzene : A member of the class of azobenzenes that is azobenzene in which one of the phenyl groups is substituted at position 3 by a methyl group, while the other is substituted at position 4 by a dimethylamino group. It is a potent liver carcinogen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sano, T1
Kagawa, M1
Okuno, M1
Ishibashi, N1
Hashimoto, M1
Yamamoto, M1
Suzuki, R1
Kohno, H1
Matsushima-Nishiwaki, R1
Takano, Y1
Tsurumi, H1
Kojima, S1
Friedman, SL1
Moriwaki, H1
Tanaka, T1

Other Studies

1 other study available for methyldimethylaminoazobenzene and Cirrhosis

ArticleYear
Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells.
    Nutrition and cancer, 2005, Volume: 51, Issue:2

    Topics: Actins; Adenoma; Animals; Antineoplastic Agents; Carcinoma; Disease Models, Animal; Disease Progress

2005